Arkansas Collaborative Practice Agreement Pharmacist
Advanced pharmacy services as part of a CPA are described as collaborative management of drug therapy (CDTM). [a] While traditional practice for pharmacists provides that the legal authority recognizes drug-related problems (DOP) and proposes solutions for PDs to prescription persons (e.g. B physicians), pharmacists who offer CDTMs solve PDs directly when they recognize them. This may include prescribing activities to select and initiate drugs to treat a patient`s diagnosed diseases (as described in the CPA), stopping the use of prescription or over-the-counter drugs, modifying a patient`s drug treatment (for example. B change in dosage, frequency, administration of medication or duration of treatment), evaluation of a patient`s reaction to drug treatment (including ordering and conducting laboratory tests, such as. B of a basic metabolic panel) and the continuation of drug therapy (provision of a new prescription).  Arkansas does not allow pharmacists to change prescriptions. The CDTM is an extension of the traditional practice of pharmacists, which helps to manage drug-related problems (PDs) led by pharmacists, with an emphasis on a collaborative and interdisciplinary approach to pharmacy practice in the health sector. The conditions of a CPA are defined by the pharmacist and the cooperating physician, although models exist online. CPAs may be specific to a patient population of interest to both parties, a specific clinical situation or disease, and/or a factual protocol for managing the drug treatment of patients under CPA. CPAs have been the subject of intensive debate in pharmacy and medicine.
For more information on the services provided by the CPA and associated pharmacists, see the following resources. This toolkit was developed by ChangeLab Solutions, the Centers for Disease Control and Prevention (CDC), the National Alliance of State Pharmacy Associations (NASPA) and the American Pharmacists Association (APhA) as part of a cooperation agreement with ChangeLab Solutions. Pharmacists who wish to develop an agreement on a community practice may need help determining where to start. To support this process, a toolkit entitled „Advancing Team-Based Care through Collaborative Practice Agreements“ has been developed. The toolkit is a resource for pharmacists that they can use in the development and implementation of collaborative practical agreements in a team-based spirit of care development. It offers a customizable model that can be used as a starting point for the development of an agreement on collaborative practices. According to health researcher Karen E. Koch, the first initiative of „collaborative management of drug therapy“ can be attributed to William A.
Zellmers in 1995 in the American Journal of Health-System Pharmacy.  Zellmer argues for the use of the term „collaborative management of drug therapy“ instead of „prescription,“ and argues that this will make laws that expand the authority of pharmacists tastier for legislators (and physician representatives). The most important is the debate on why pharmacists are interested in extending this authority: improving patient care through interdisciplinary cooperation.  The modern concept of collaborative practice has been partly derived from the controversial notion of dependent prescribing authority.  Once authorized by the Board of Pharmacy, APh can conduct patient assessments, refer patients to providers, and work with other health care providers to manage patients` disease status by optimizing drug treatments.